Last week, the FDA and CDC presented their recommendations for the newest round of COVID-19 vaccines. As with everything COVID, there are proponents and detractors, or, putting it another way, both knowledgeable experts and disinformation-spreading attention-seekers. The reality is that a group of experts made a judgment based on actual data.  We discuss the evidence here so you can make your own informed decision.
There are upticks in early indicators of a COVID surge, including hospitalizations, test positivity, and SARS-CoV-2 concentrations in wastewater. And a new Omicron subvariant is rapidly gaining in prevalence. We need to prepare.
As the COVID pandemic moves further into our rearview mirrors, questions have been raised about a more prolonged manifestation of COVID, Long COVID. Now, there seems to be a concern about more prolonged symptoms from the COVID vaccines; we can call it Long Vax. What do we know and don’t know?
Long COVID remains chimeric, more a litany of symptoms than a clearcut “disease.” Perhaps a clustering of symptoms might reveal the underlying picture. Researchers using lots of data and statistical analysis identify some patterns.
Long COVID remains an enigma wrapped within a conundrum. Many individuals claim the affliction. But without a consensus on its diagnosis, unraveling its underlying physiologic changes, let alone therapeutic approaches, is a random walk. It's a lot a drunk searching for their keys under a streetlamp because the light is better. Two developments this week may well begin the unwrapping.
Long COVID burdens tens of millions of Americans and the nation's healthcare system, but our response to it has been fragmented and chaotic. We need to address it without delay, with more research and better access to treatment.
COVID is still killing more than 1,000 Americans a week; long COVID causes prolonged misery; and a new, more transmissible subvariant of the SARS-CoV-2 virus is spreading.
Long COVID will take a toll on the nation's healthcare system for the foreseeable future, but we can reduce new cases by treating acute COVID infections with a commonly prescribed, inexpensive medicine.
There are plenty of reasons for skepticism about medical studies. Some are poorly designed or performed, and some conclusions are totally implausible. In addition, some interpretations of them are intentionally misleading, and some studies need not have been done at all.
Long COVID remains a riddle wrapped in a mystery inside an enigma. It wants so hard to be a disease but remains a syndrome, a collection of ill-defined signs and symptoms. Can Big Data help Long COVID and its sufferers separate themselves from other viral infections? A new study tries.
The most infectious subvariant of the SARS-CoV-2 virus yet discovered is spreading through the U.S., and experts are predicting a January-February surge of COVID cases. A corollary is that we will also have more cases of long COVID, which is worrisome given new findings that long COVID, like acute infections, can be fatal. The best way to avoid long COVID is not to get infected in the first place.
Long COVID – the persistence of symptoms long past COVID’s normal recovery – remains in uncharted diagnostic waters. It’s a syndrome of symptoms rather than a specific disease. A new study from China sheds some light on who is at risk, and what symptoms they might have.